• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Comparison of 1,2-dihydropyrido[3,4-b]pyrazines (1-deaza-7,8-dihydropteridines) with several other inhibitors of mitosis.

作者信息

Bowdon B J, Waud W R, Wheeler G P, Hain R, Dansby L, Temple C

出版信息

Cancer Res. 1987 Mar 15;47(6):1621-6.

PMID:3815360
Abstract

Several properties of four 1-deaza-7,8-dihydropteridines were compared with those of each other and with those of colchicine, nocodazole, podophyllotoxin, and vincristine. Compound NSC 370147 was more active than the other compounds of this type with respect to inhibition of proliferation of cultured L1210 cells and to increase of the mitotic index. On an equimolar basis it was more active than two of the 1-deaza-7,8-dihydropteridines, colchicine, and nocodazole and was comparable to podophyllotoxin and vincristine in inhibiting the polymerization of partially purified pig brain tubulin. All four of the 1-deaza-7,8-dihydropteridines caused decreases in the extent of binding of [3H]colchicine to partially purified tubulin and enhanced the binding of [3H]vincristine to the tubulin. Emphasis in further testing was placed upon NSC 370147, because it is easier to synthesize and is more stable than some of the other compounds of this type and because its greater solubility in water facilitates its formulation for therapeutic administration. Compound NSC 370147 inhibited competitively the binding of [3H]colchicine to purified tubulin and enhanced slightly the binding of [3H]vincristine to tubulin. It was also synergistic with vincristine in killing cultured L1210 cells and in increasing the life-spans of mice bearing P388 leukemia. It is suggested that it would be worthwhile to evaluate combinations of NSC 370147 and vincristine in tests with other experimental neoplasms.

摘要

相似文献

1
Comparison of 1,2-dihydropyrido[3,4-b]pyrazines (1-deaza-7,8-dihydropteridines) with several other inhibitors of mitosis.
Cancer Res. 1987 Mar 15;47(6):1621-6.
2
Biological effects and structure-activity relationships of 1,2-dihydropyrido[3,4-b]pyrazines.1,2 - 二氢吡啶并[3,4 - b]吡嗪的生物学效应及构效关系
Cancer Res. 1983 Aug;43(8):3567-75.
3
Mechanism of action of E7010, an orally active sulfonamide antitumor agent: inhibition of mitosis by binding to the colchicine site of tubulin.口服活性磺酰胺类抗肿瘤药物E7010的作用机制:通过与微管蛋白的秋水仙碱结合位点结合来抑制有丝分裂。
Cancer Res. 1997 Aug 1;57(15):3208-13.
4
1,2-Dihydropyrido[3,4-b]pyrazines: structure-activity relationships.1,2 - 二氢吡啶并[3,4 - b]吡嗪:构效关系
J Med Chem. 1983 Jan;26(1):91-5. doi: 10.1021/jm00355a018.
5
Inhibition of mitosis and anticancer activity against experimental neoplasms by ethyl 5-amino-1,2-dihydro-3-[(N-methylanilino)methyl]-pyrido[3,4-b]pyrazin-7-ylcarbamate (NSC 181928).5-氨基-1,2-二氢-3-[(N-甲基苯胺基)甲基]-吡啶并[3,4-b]吡嗪-7-基氨基甲酸乙酯(NSC 181928)对有丝分裂的抑制作用及对实验性肿瘤的抗癌活性
Cancer Res. 1982 Mar;42(3):791-8.
6
Structure-function studies with derivatives of 6-benzyl-1,3-benzodioxole, a new class of synthetic compounds which inhibit tubulin polymerization and mitosis.对6-苄基-1,3-苯并二恶唑衍生物进行的结构-功能研究,这是一类新型合成化合物,可抑制微管蛋白聚合和有丝分裂。
Mol Pharmacol. 1985 Jan;27(1):94-102.
7
Correlation of tubulin-binding and antitumor activities of podophyllotoxin analogs.鬼臼毒素类似物的微管蛋白结合活性与抗肿瘤活性的相关性
Cancer Treat Rep. 1978 Oct;62(10):1443-7.
8
Tubulin-dependent hydrolysis of guanosine triphosphate as a screening test to identify new antitubulin compounds with potential as antimitotic agents: application to carbamates of aromatic amines.将鸟苷三磷酸的微管蛋白依赖性水解作为一种筛选试验,以鉴定具有作为抗有丝分裂剂潜力的新型抗微管蛋白化合物:应用于芳香胺的氨基甲酸盐。
Cancer Res. 1989 Mar 15;49(6):1344-8.
9
Tricyclic pyrone analogs: a new synthetic class of bifunctional anticancer drugs that inhibit nucleoside transport, microtubule assembly, the viability of leukemic cells in vitro and the growth of solid tumors in vivo.三环吡喃类似物:一类新型合成双功能抗癌药物,可抑制核苷转运、微管组装、体外白血病细胞活力及体内实体瘤生长。
Anticancer Drugs. 1999 Jun;10(5):489-504.
10
Derivatives of 5,6-diphenylpyridazin-3-one: synthetic antimitotic agents which interact with plant and mammalian tubulin at a new drug-binding site.5,6-二苯基哒嗪-3-酮衍生物:在一个新的药物结合位点与植物和哺乳动物微管蛋白相互作用的合成抗有丝分裂剂。
Cancer Res. 1986 Apr;46(4 Pt 2):1889-93.

引用本文的文献

1
New small-molecule synthetic antimycobacterials.新型小分子合成抗分枝杆菌药物。
Antimicrob Agents Chemother. 2005 Jun;49(6):2153-63. doi: 10.1128/AAC.49.6.2153-2163.2005.
2
Phase II trial of CI-980 in patients with disseminated malignant melanoma and no prior chemotherapy. A Southwest Oncology Group study.CI-980用于播散性恶性黑色素瘤且未接受过化疗患者的II期试验。西南肿瘤协作组的一项研究。
Invest New Drugs. 2001;19(3):239-43. doi: 10.1023/a:1010624702340.
3
Slow polymerization of Mycobacterium tuberculosis FtsZ.结核分枝杆菌FtsZ的缓慢聚合
J Bacteriol. 2000 Jul;182(14):4028-34. doi: 10.1128/JB.182.14.4028-4034.2000.
4
CI-980 in advanced melanoma and hormone refractory prostate cancer.
Invest New Drugs. 2000 May;18(2):187-91. doi: 10.1023/a:1006382014403.
5
Phase II study of CI-980 (NSC 635370) in patients with previously treated advanced soft-tissue sarcomas.CI-980(NSC 635370)用于既往接受过治疗的晚期软组织肉瘤患者的II期研究。
Invest New Drugs. 1998;16(1):87-92. doi: 10.1023/a:1006078930550.
6
A phase I trial and pharmacokinetic evaluation of CI-980 in patients with advanced solid tumors.
Invest New Drugs. 1997;15(3):235-46. doi: 10.1023/a:1005854510468.
7
Cellular transport of CI-980.
Invest New Drugs. 1996;14(4):341-7. doi: 10.1007/BF00180809.
8
Extravasation injury potential of CI-980, a novel synthetic mitotic inhibitor.新型合成有丝分裂抑制剂CI-980的外渗损伤可能性
Cancer Chemother Pharmacol. 1993;32(5):365-7. doi: 10.1007/BF00735920.
9
Mode of action of tubulozoles against Plasmodium falciparum in vitro.微管唑类药物对恶性疟原虫的体外作用机制
Antimicrob Agents Chemother. 1990 Aug;34(8):1529-34. doi: 10.1128/AAC.34.8.1529.
10
Antitumor drug cross-resistance in vivo in a murine P388 leukemia resistant to ethyl 5-amino-1,2-dihydro-2-methyl-3-phenylpyrido[3,4-b]pyrazin-7 - ylcarbamate 2-hydroxyethanesulfonate hydrate (NSC 370,147) 370147.对5-氨基-1,2-二氢-2-甲基-3-苯基吡啶并[3,4-b]吡嗪-7-基氨基甲酸乙酯2-羟基乙磺酸盐一水合物(NSC 370,147)耐药的小鼠P388白血病体内抗肿瘤药物交叉耐药性 370147
Cancer Chemother Pharmacol. 1992;29(3):190-4. doi: 10.1007/BF00686251.